Elixiron Immunotherapeutics
PrivateLast Round
Series B
Jun 12, 2025
Total Funding Raised
$70M
Momentum Score
50 /100
Company Overview
Elixiron Immunotherapeutics is a clinical-stage biotechnology company that develops precision immunotherapies for neuroinflammatory diseases, autoimmune diseases, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elixiron Immunotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Elixiron Immunotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 12, 2025 | ||||
| Grant | Jul 12, 2022 | ||||
| Series A Extension | Aug 23, 2021 | ||||
| Grant | Aug 25, 2020 | ||||
| Series A | Jul 31, 2019 |
Key People
Founding team and executive leadership
Elixiron Immunotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series A, Series A Extension |
| Fubon Financial Holding Venture Capital | Series A Extension |
| CDIB Capital International | Series A |
| China Investment & Development Company, Limited | Series A Extension |
| Alzheimer's Association | Grant |
| Fubon Financial Holdings | Series A Extension |
Elixiron Immunotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elixiron Immunotherapeutics's valuation, stock price, and market status.
